Titre : Lymphocytes

Lymphocytes : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une lymphopénie ?

Un hémogramme révèle un faible nombre de lymphocytes dans le sang.
Lymphopénie Hémogramme
#2

Quels tests pour évaluer les lymphocytes T ?

Des tests de cytométrie en flux mesurent les sous-populations de lymphocytes T.
Lymphocytes T Cytométrie en flux
#3

Quels signes indiquent une infection virale ?

Une augmentation des lymphocytes dans le sang peut indiquer une infection virale.
Infection virale Lymphocytes
#4

Comment détecter une leucémie lymphoïde ?

Un examen sanguin et une biopsie de moelle osseuse sont nécessaires pour le diagnostic.
Leucémie lymphoïde Biopsie de moelle osseuse
#5

Quels marqueurs pour les lymphocytes B ?

Les marqueurs CD19 et CD20 sont utilisés pour identifier les lymphocytes B.
Lymphocytes B Marqueurs

Symptômes 5

#1

Quels symptômes d'une lymphopénie ?

Les symptômes incluent des infections fréquentes et une fatigue persistante.
Lymphopénie Infections
#2

Comment se manifeste une hyperlymphocytose ?

Elle se manifeste par des infections récurrentes et des symptômes d'inflammation.
Hyperlymphocytose Inflammation
#3

Quels signes d'une maladie auto-immune ?

Fatigue, douleurs articulaires et éruptions cutanées peuvent indiquer une maladie auto-immune.
Maladie auto-immune Fatigue
#4

Quels symptômes d'une leucémie ?

Symptômes incluent fièvre, perte de poids, et saignements inexpliqués.
Leucémie Saignements
#5

Quels symptômes d'une infection virale ?

Fièvre, maux de tête et douleurs musculaires sont fréquents lors d'infections virales.
Infection virale Fièvre

Prévention 5

#1

Comment prévenir les infections ?

Une bonne hygiène, des vaccinations et un mode de vie sain aident à prévenir les infections.
Prévention des infections Vaccinations
#2

Quels conseils pour renforcer le système immunitaire ?

Une alimentation équilibrée, l'exercice régulier et le sommeil suffisant renforcent l'immunité.
Système immunitaire Alimentation équilibrée
#3

Comment éviter les maladies auto-immunes ?

Éviter les toxines environnementales et gérer le stress peut réduire le risque.
Maladies auto-immunes Toxines
#4

Quels vaccins pour les lymphocytes ?

Les vaccins contre la grippe et l'hépatite renforcent la réponse des lymphocytes.
Vaccins Lymphocytes
#5

Comment réduire le risque de leucémie ?

Éviter l'exposition à des produits chimiques nocifs peut réduire le risque de leucémie.
Leucémie Produits chimiques nocifs

Traitements 5

#1

Comment traiter une lymphopénie ?

Le traitement dépend de la cause sous-jacente et peut inclure des médicaments immunosuppresseurs.
Lymphopénie Immunosuppresseurs
#2

Quels traitements pour la leucémie lymphoïde ?

Les traitements incluent chimiothérapie, immunothérapie et parfois greffe de moelle osseuse.
Leucémie lymphoïde Chimiothérapie
#3

Comment gérer une hyperlymphocytose ?

Le traitement vise à traiter la cause sous-jacente, comme une infection ou une maladie.
Hyperlymphocytose Infection
#4

Quels médicaments pour les lymphocytes T ?

Des thérapies ciblées et des inhibiteurs de points de contrôle immunitaire sont utilisés.
Lymphocytes T Thérapies ciblées
#5

Comment traiter les maladies auto-immunes ?

Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation.
Maladies auto-immunes Corticostéroïdes

Complications 5

#1

Quelles complications d'une lymphopénie ?

Les complications incluent des infections graves et des maladies opportunistes.
Lymphopénie Infections graves
#2

Quels risques d'une hyperlymphocytose ?

Elle peut entraîner des complications comme des troubles auto-immuns ou des leucémies.
Hyperlymphocytose Troubles auto-immuns
#3

Quelles complications des maladies auto-immunes ?

Les complications peuvent inclure des dommages aux organes et une diminution de la qualité de vie.
Maladies auto-immunes Dommages aux organes
#4

Quels risques liés à la leucémie ?

Les risques incluent des infections, des saignements et des complications liées au traitement.
Leucémie Infections
#5

Quelles complications des traitements immunosuppresseurs ?

Les traitements peuvent augmenter le risque d'infections et de cancers secondaires.
Immunosuppresseurs Infections

Facteurs de risque 5

#1

Quels facteurs de risque pour la lymphopénie ?

Les infections chroniques, certains médicaments et les maladies auto-immunes augmentent le risque.
Lymphopénie Maladies auto-immunes
#2

Quels facteurs de risque pour la leucémie ?

L'exposition à des radiations, des produits chimiques et des antécédents familiaux sont des facteurs de risque.
Leucémie Radiations
#3

Quels facteurs influencent l'hyperlymphocytose ?

Les infections, les maladies inflammatoires et certains cancers peuvent influencer l'hyperlymphocytose.
Hyperlymphocytose Maladies inflammatoires
#4

Quels facteurs de risque pour les maladies auto-immunes ?

Les facteurs génétiques, environnementaux et hormonaux peuvent augmenter le risque.
Maladies auto-immunes Facteurs génétiques
#5

Comment le mode de vie affecte-t-il les lymphocytes ?

Un mode de vie malsain, comme le tabagisme et une mauvaise alimentation, peut affaiblir les lymphocytes.
Mode de vie Lymphocytes
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Lymphocytes : Questions médicales les plus fréquentes", "headline": "Lymphocytes : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Lymphocytes : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2026-03-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Lymphocytes" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Agranulocytes", "url": "https://questionsmedicales.fr/mesh/D007963", "about": { "@type": "MedicalCondition", "name": "Agranulocytes", "code": { "@type": "MedicalCode", "code": "D007963", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cellules tueuses naturelles", "alternateName": "Killer Cells, Natural", "url": "https://questionsmedicales.fr/mesh/D007694", "about": { "@type": "MedicalCondition", "name": "Cellules tueuses naturelles", "code": { "@type": "MedicalCode", "code": "D007694", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.537" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cellules LAK", "alternateName": "Killer Cells, Lymphokine-Activated", "url": "https://questionsmedicales.fr/mesh/D015979", "about": { "@type": "MedicalCondition", "name": "Cellules LAK", "code": { "@type": "MedicalCode", "code": "D015979", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.537.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Sous-populations de lymphocytes", "alternateName": "Lymphocyte Subsets", "url": "https://questionsmedicales.fr/mesh/D016131", "about": { "@type": "MedicalCondition", "name": "Sous-populations de lymphocytes", "code": { "@type": "MedicalCode", "code": "D016131", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.550" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes B", "alternateName": "B-Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D001402", "about": { "@type": "MedicalCondition", "name": "Lymphocytes B", "code": { "@type": "MedicalCode", "code": "D001402", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Sous-populations de lymphocytes B", "alternateName": "B-Lymphocyte Subsets", "url": "https://questionsmedicales.fr/mesh/D016175", "about": { "@type": "MedicalCondition", "name": "Sous-populations de lymphocytes B", "code": { "@type": "MedicalCode", "code": "D016175", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.450" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lymphocytes B régulateurs", "alternateName": "B-Lymphocytes, Regulatory", "url": "https://questionsmedicales.fr/mesh/D060151", "about": { "@type": "MedicalCondition", "name": "Lymphocytes B régulateurs", "code": { "@type": "MedicalCode", "code": "D060151", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.450.300" } } }, { "@type": "MedicalWebPage", "name": "Cellules B mémoire", "alternateName": "Memory B Cells", "url": "https://questionsmedicales.fr/mesh/D000091245", "about": { "@type": "MedicalCondition", "name": "Cellules B mémoire", "code": { "@type": "MedicalCode", "code": "D000091245", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.450.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes B régulateurs", "alternateName": "B-Lymphocytes, Regulatory", "url": "https://questionsmedicales.fr/mesh/D060151", "about": { "@type": "MedicalCondition", "name": "Lymphocytes B régulateurs", "code": { "@type": "MedicalCode", "code": "D060151", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.450.300" } } }, { "@type": "MedicalWebPage", "name": "Cellules B mémoire", "alternateName": "Memory B Cells", "url": "https://questionsmedicales.fr/mesh/D000091245", "about": { "@type": "MedicalCondition", "name": "Cellules B mémoire", "code": { "@type": "MedicalCode", "code": "D000091245", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.450.650" } } }, { "@type": "MedicalWebPage", "name": "Plasmocytes", "alternateName": "Plasma Cells", "url": "https://questionsmedicales.fr/mesh/D010950", "about": { "@type": "MedicalCondition", "name": "Plasmocytes", "code": { "@type": "MedicalCode", "code": "D010950", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.562.725" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes T", "alternateName": "T-Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D013601", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T", "code": { "@type": "MedicalCode", "code": "D013601", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lymphocytes T CD4+", "alternateName": "CD4-Positive T-Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D015496", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T CD4+", "code": { "@type": "MedicalCode", "code": "D015496", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.200" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T CD8+", "alternateName": "CD8-Positive T-Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D018414", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T CD8+", "code": { "@type": "MedicalCode", "code": "D018414", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.220" } } }, { "@type": "MedicalWebPage", "name": "Cellules Jurkat", "alternateName": "Jurkat Cells", "url": "https://questionsmedicales.fr/mesh/D019169", "about": { "@type": "MedicalCondition", "name": "Cellules Jurkat", "code": { "@type": "MedicalCode", "code": "D019169", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.440" } } }, { "@type": "MedicalWebPage", "name": "Cellules T tueuses naturelles", "alternateName": "Natural Killer T-Cells", "url": "https://questionsmedicales.fr/mesh/D055611", "about": { "@type": "MedicalCondition", "name": "Cellules T tueuses naturelles", "code": { "@type": "MedicalCode", "code": "D055611", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.470" } } }, { "@type": "MedicalWebPage", "name": "Sous-populations de lymphocytes T", "alternateName": "T-Lymphocyte Subsets", "url": "https://questionsmedicales.fr/mesh/D016176", "about": { "@type": "MedicalCondition", "name": "Sous-populations de lymphocytes T", "code": { "@type": "MedicalCode", "code": "D016176", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lymphocytes intra-épithéliaux", "alternateName": "Intraepithelial Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D000075942", "about": { "@type": "MedicalCondition", "name": "Lymphocytes intra-épithéliaux", "code": { "@type": "MedicalCode", "code": "D000075942", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.050" } } }, { "@type": "MedicalWebPage", "name": "Cellules T mémoire", "alternateName": "Memory T Cells", "url": "https://questionsmedicales.fr/mesh/D000091246", "about": { "@type": "MedicalCondition", "name": "Cellules T mémoire", "code": { "@type": "MedicalCode", "code": "D000091246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.075" } } }, { "@type": "MedicalWebPage", "name": "Cellules T invariantes associées aux muqueuses", "alternateName": "Mucosal-Associated Invariant T Cells", "url": "https://questionsmedicales.fr/mesh/D000072336", "about": { "@type": "MedicalCondition", "name": "Cellules T invariantes associées aux muqueuses", "code": { "@type": "MedicalCode", "code": "D000072336", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.100" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T cytotoxiques", "alternateName": "T-Lymphocytes, Cytotoxic", "url": "https://questionsmedicales.fr/mesh/D013602", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T cytotoxiques", "code": { "@type": "MedicalCode", "code": "D013602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.200" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires", "alternateName": "T-Lymphocytes, Helper-Inducer", "url": "https://questionsmedicales.fr/mesh/D006377", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires", "code": { "@type": "MedicalCode", "code": "D006377", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires folliculaires", "alternateName": "T Follicular Helper Cells", "url": "https://questionsmedicales.fr/mesh/D000084522", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires folliculaires", "code": { "@type": "MedicalCode", "code": "D000084522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.450" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th1", "alternateName": "Th1 Cells", "url": "https://questionsmedicales.fr/mesh/D018417", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th1", "code": { "@type": "MedicalCode", "code": "D018417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.900" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th2", "alternateName": "Th2 Cells", "url": "https://questionsmedicales.fr/mesh/D018418", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th2", "code": { "@type": "MedicalCode", "code": "D018418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.905" } } }, { "@type": "MedicalWebPage", "name": "Cellules Th17", "alternateName": "Th17 Cells", "url": "https://questionsmedicales.fr/mesh/D058504", "about": { "@type": "MedicalCondition", "name": "Cellules Th17", "code": { "@type": "MedicalCode", "code": "D058504", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.915" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires folliculaires", "alternateName": "T Follicular Helper Cells", "url": "https://questionsmedicales.fr/mesh/D000084522", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires folliculaires", "code": { "@type": "MedicalCode", "code": "D000084522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.450" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th1", "alternateName": "Th1 Cells", "url": "https://questionsmedicales.fr/mesh/D018417", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th1", "code": { "@type": "MedicalCode", "code": "D018417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.900" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th2", "alternateName": "Th2 Cells", "url": "https://questionsmedicales.fr/mesh/D018418", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th2", "code": { "@type": "MedicalCode", "code": "D018418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.905" } } }, { "@type": "MedicalWebPage", "name": "Cellules Th17", "alternateName": "Th17 Cells", "url": "https://questionsmedicales.fr/mesh/D058504", "about": { "@type": "MedicalCondition", "name": "Cellules Th17", "code": { "@type": "MedicalCode", "code": "D058504", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.915" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T régulateurs", "alternateName": "T-Lymphocytes, Regulatory", "url": "https://questionsmedicales.fr/mesh/D050378", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T régulateurs", "code": { "@type": "MedicalCode", "code": "D050378", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes intra-épithéliaux", "alternateName": "Intraepithelial Lymphocytes", "url": "https://questionsmedicales.fr/mesh/D000075942", "about": { "@type": "MedicalCondition", "name": "Lymphocytes intra-épithéliaux", "code": { "@type": "MedicalCode", "code": "D000075942", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.050" } } }, { "@type": "MedicalWebPage", "name": "Cellules T mémoire", "alternateName": "Memory T Cells", "url": "https://questionsmedicales.fr/mesh/D000091246", "about": { "@type": "MedicalCondition", "name": "Cellules T mémoire", "code": { "@type": "MedicalCode", "code": "D000091246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.075" } } }, { "@type": "MedicalWebPage", "name": "Cellules T invariantes associées aux muqueuses", "alternateName": "Mucosal-Associated Invariant T Cells", "url": "https://questionsmedicales.fr/mesh/D000072336", "about": { "@type": "MedicalCondition", "name": "Cellules T invariantes associées aux muqueuses", "code": { "@type": "MedicalCode", "code": "D000072336", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.100" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T cytotoxiques", "alternateName": "T-Lymphocytes, Cytotoxic", "url": "https://questionsmedicales.fr/mesh/D013602", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T cytotoxiques", "code": { "@type": "MedicalCode", "code": "D013602", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.200" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires", "alternateName": "T-Lymphocytes, Helper-Inducer", "url": "https://questionsmedicales.fr/mesh/D006377", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires", "code": { "@type": "MedicalCode", "code": "D006377", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires folliculaires", "alternateName": "T Follicular Helper Cells", "url": "https://questionsmedicales.fr/mesh/D000084522", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires folliculaires", "code": { "@type": "MedicalCode", "code": "D000084522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.450" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th1", "alternateName": "Th1 Cells", "url": "https://questionsmedicales.fr/mesh/D018417", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th1", "code": { "@type": "MedicalCode", "code": "D018417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.900" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th2", "alternateName": "Th2 Cells", "url": "https://questionsmedicales.fr/mesh/D018418", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th2", "code": { "@type": "MedicalCode", "code": "D018418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.905" } } }, { "@type": "MedicalWebPage", "name": "Cellules Th17", "alternateName": "Th17 Cells", "url": "https://questionsmedicales.fr/mesh/D058504", "about": { "@type": "MedicalCondition", "name": "Cellules Th17", "code": { "@type": "MedicalCode", "code": "D058504", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.915" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes T auxiliaires folliculaires", "alternateName": "T Follicular Helper Cells", "url": "https://questionsmedicales.fr/mesh/D000084522", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T auxiliaires folliculaires", "code": { "@type": "MedicalCode", "code": "D000084522", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.450" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th1", "alternateName": "Th1 Cells", "url": "https://questionsmedicales.fr/mesh/D018417", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th1", "code": { "@type": "MedicalCode", "code": "D018417", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.900" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes auxiliaires Th2", "alternateName": "Th2 Cells", "url": "https://questionsmedicales.fr/mesh/D018418", "about": { "@type": "MedicalCondition", "name": "Lymphocytes auxiliaires Th2", "code": { "@type": "MedicalCode", "code": "D018418", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.905" } } }, { "@type": "MedicalWebPage", "name": "Cellules Th17", "alternateName": "Th17 Cells", "url": "https://questionsmedicales.fr/mesh/D058504", "about": { "@type": "MedicalCondition", "name": "Cellules Th17", "code": { "@type": "MedicalCode", "code": "D058504", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.400.915" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes T régulateurs", "alternateName": "T-Lymphocytes, Regulatory", "url": "https://questionsmedicales.fr/mesh/D050378", "about": { "@type": "MedicalCondition", "name": "Lymphocytes T régulateurs", "code": { "@type": "MedicalCode", "code": "D050378", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.569.500.700" } } } ] }, { "@type": "MedicalWebPage", "name": "Lymphocytes nuls", "alternateName": "Lymphocytes, Null", "url": "https://questionsmedicales.fr/mesh/D008215", "about": { "@type": "MedicalCondition", "name": "Lymphocytes nuls", "code": { "@type": "MedicalCode", "code": "D008215", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.622" } } }, { "@type": "MedicalWebPage", "name": "Lymphocytes TIL", "alternateName": "Lymphocytes, Tumor-Infiltrating", "url": "https://questionsmedicales.fr/mesh/D016246", "about": { "@type": "MedicalCondition", "name": "Lymphocytes TIL", "code": { "@type": "MedicalCode", "code": "D016246", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "A15.382.490.555.567.650" } } } ], "about": { "@type": "MedicalCondition", "name": "Lymphocytes", "alternateName": "Lymphocytes", "code": { "@type": "MedicalCode", "code": "D008214", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Joanna Huszno", "url": "https://questionsmedicales.fr/author/Joanna%20Huszno", "affiliation": { "@type": "Organization", "name": "I Radiation and Clinic Oncology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland." } }, { "@type": "Person", "name": "Xiaoyu Zhu", "url": "https://questionsmedicales.fr/author/Xiaoyu%20Zhu", "affiliation": { "@type": "Organization", "name": "Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China." } }, { "@type": "Person", "name": "Jia Zhou", "url": "https://questionsmedicales.fr/author/Jia%20Zhou", "affiliation": { "@type": "Organization", "name": "Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China." } }, { "@type": "Person", "name": "Yu Zhu", "url": "https://questionsmedicales.fr/author/Yu%20Zhu", "affiliation": { "@type": "Organization", "name": "Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China." } }, { "@type": "Person", "name": "Xiaole Han", "url": "https://questionsmedicales.fr/author/Xiaole%20Han", "affiliation": { "@type": "Organization", "name": "Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Monocyte-to-lymphocyte, neutrophil-to-lymphocyte and neutrophil-to-monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study.", "datePublished": "2023-08-14", "url": "https://questionsmedicales.fr/article/37540888", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1111/apa.16932" } }, { "@type": "ScholarlyArticle", "name": "Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study.", "datePublished": "2024-04-24", "url": "https://questionsmedicales.fr/article/38655656", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.2340/actadv.v104.27571" } }, { "@type": "ScholarlyArticle", "name": "Preoperative lymphocyte count, neutrophil to lymphocyte and platelet to lymphocyte ratio predict the recurrence with progression and cancerization in vocal fold lesions-retrospective study.", "datePublished": "2023-09-20", "url": "https://questionsmedicales.fr/article/37744219", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.7717/peerj.15642" } }, { "@type": "ScholarlyArticle", "name": "Role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in diagnosing neonatal sepsis.", "datePublished": "2024-05-31", "url": "https://questionsmedicales.fr/article/39280270", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.52225/narra.v4i2.763" } }, { "@type": "ScholarlyArticle", "name": "Platelet-to-lymphocyte, neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios are related to cancer-related fatigue and quality of life in patients with cancer: a cross-sectional study.", "datePublished": "2023-12-06", "url": "https://questionsmedicales.fr/article/38056937", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1136/bmjopen-2023-075398" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Systèmes sanguin et immunitaire", "item": "https://questionsmedicales.fr/mesh/D006424" }, { "@type": "ListItem", "position": 3, "name": "Système immunitaire", "item": "https://questionsmedicales.fr/mesh/D007107" }, { "@type": "ListItem", "position": 4, "name": "Leucocytes", "item": "https://questionsmedicales.fr/mesh/D007962" }, { "@type": "ListItem", "position": 5, "name": "Agranulocytes", "item": "https://questionsmedicales.fr/mesh/D007963" }, { "@type": "ListItem", "position": 6, "name": "Lymphocytes", "item": "https://questionsmedicales.fr/mesh/D008214" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Lymphocytes - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Lymphocytes", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-10", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Lymphocytes", "description": "Comment diagnostiquer une lymphopénie ?\nQuels tests pour évaluer les lymphocytes T ?\nQuels signes indiquent une infection virale ?\nComment détecter une leucémie lymphoïde ?\nQuels marqueurs pour les lymphocytes B ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Lymphocytes", "description": "Quels symptômes d'une lymphopénie ?\nComment se manifeste une hyperlymphocytose ?\nQuels signes d'une maladie auto-immune ?\nQuels symptômes d'une leucémie ?\nQuels symptômes d'une infection virale ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Lymphocytes", "description": "Comment prévenir les infections ?\nQuels conseils pour renforcer le système immunitaire ?\nComment éviter les maladies auto-immunes ?\nQuels vaccins pour les lymphocytes ?\nComment réduire le risque de leucémie ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Lymphocytes", "description": "Comment traiter une lymphopénie ?\nQuels traitements pour la leucémie lymphoïde ?\nComment gérer une hyperlymphocytose ?\nQuels médicaments pour les lymphocytes T ?\nComment traiter les maladies auto-immunes ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Lymphocytes", "description": "Quelles complications d'une lymphopénie ?\nQuels risques d'une hyperlymphocytose ?\nQuelles complications des maladies auto-immunes ?\nQuels risques liés à la leucémie ?\nQuelles complications des traitements immunosuppresseurs ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Lymphocytes", "description": "Quels facteurs de risque pour la lymphopénie ?\nQuels facteurs de risque pour la leucémie ?\nQuels facteurs influencent l'hyperlymphocytose ?\nQuels facteurs de risque pour les maladies auto-immunes ?\nComment le mode de vie affecte-t-il les lymphocytes ?", "url": "https://questionsmedicales.fr/mesh/D008214#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une lymphopénie ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un hémogramme révèle un faible nombre de lymphocytes dans le sang." } }, { "@type": "Question", "name": "Quels tests pour évaluer les lymphocytes T ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de cytométrie en flux mesurent les sous-populations de lymphocytes T." } }, { "@type": "Question", "name": "Quels signes indiquent une infection virale ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Une augmentation des lymphocytes dans le sang peut indiquer une infection virale." } }, { "@type": "Question", "name": "Comment détecter une leucémie lymphoïde ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un examen sanguin et une biopsie de moelle osseuse sont nécessaires pour le diagnostic." } }, { "@type": "Question", "name": "Quels marqueurs pour les lymphocytes B ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les marqueurs CD19 et CD20 sont utilisés pour identifier les lymphocytes B." } }, { "@type": "Question", "name": "Quels symptômes d'une lymphopénie ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des infections fréquentes et une fatigue persistante." } }, { "@type": "Question", "name": "Comment se manifeste une hyperlymphocytose ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Elle se manifeste par des infections récurrentes et des symptômes d'inflammation." } }, { "@type": "Question", "name": "Quels signes d'une maladie auto-immune ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Fatigue, douleurs articulaires et éruptions cutanées peuvent indiquer une maladie auto-immune." } }, { "@type": "Question", "name": "Quels symptômes d'une leucémie ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Symptômes incluent fièvre, perte de poids, et saignements inexpliqués." } }, { "@type": "Question", "name": "Quels symptômes d'une infection virale ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, maux de tête et douleurs musculaires sont fréquents lors d'infections virales." } }, { "@type": "Question", "name": "Comment prévenir les infections ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène, des vaccinations et un mode de vie sain aident à prévenir les infections." } }, { "@type": "Question", "name": "Quels conseils pour renforcer le système immunitaire ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée, l'exercice régulier et le sommeil suffisant renforcent l'immunité." } }, { "@type": "Question", "name": "Comment éviter les maladies auto-immunes ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les toxines environnementales et gérer le stress peut réduire le risque." } }, { "@type": "Question", "name": "Quels vaccins pour les lymphocytes ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccins contre la grippe et l'hépatite renforcent la réponse des lymphocytes." } }, { "@type": "Question", "name": "Comment réduire le risque de leucémie ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition à des produits chimiques nocifs peut réduire le risque de leucémie." } }, { "@type": "Question", "name": "Comment traiter une lymphopénie ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement dépend de la cause sous-jacente et peut inclure des médicaments immunosuppresseurs." } }, { "@type": "Question", "name": "Quels traitements pour la leucémie lymphoïde ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent chimiothérapie, immunothérapie et parfois greffe de moelle osseuse." } }, { "@type": "Question", "name": "Comment gérer une hyperlymphocytose ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement vise à traiter la cause sous-jacente, comme une infection ou une maladie." } }, { "@type": "Question", "name": "Quels médicaments pour les lymphocytes T ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Des thérapies ciblées et des inhibiteurs de points de contrôle immunitaire sont utilisés." } }, { "@type": "Question", "name": "Comment traiter les maladies auto-immunes ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des corticostéroïdes et des immunosuppresseurs pour réduire l'inflammation." } }, { "@type": "Question", "name": "Quelles complications d'une lymphopénie ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des infections graves et des maladies opportunistes." } }, { "@type": "Question", "name": "Quels risques d'une hyperlymphocytose ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elle peut entraîner des complications comme des troubles auto-immuns ou des leucémies." } }, { "@type": "Question", "name": "Quelles complications des maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Les complications peuvent inclure des dommages aux organes et une diminution de la qualité de vie." } }, { "@type": "Question", "name": "Quels risques liés à la leucémie ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Les risques incluent des infections, des saignements et des complications liées au traitement." } }, { "@type": "Question", "name": "Quelles complications des traitements immunosuppresseurs ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent augmenter le risque d'infections et de cancers secondaires." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la lymphopénie ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les infections chroniques, certains médicaments et les maladies auto-immunes augmentent le risque." } }, { "@type": "Question", "name": "Quels facteurs de risque pour la leucémie ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition à des radiations, des produits chimiques et des antécédents familiaux sont des facteurs de risque." } }, { "@type": "Question", "name": "Quels facteurs influencent l'hyperlymphocytose ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Les infections, les maladies inflammatoires et certains cancers peuvent influencer l'hyperlymphocytose." } }, { "@type": "Question", "name": "Quels facteurs de risque pour les maladies auto-immunes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs génétiques, environnementaux et hormonaux peuvent augmenter le risque." } }, { "@type": "Question", "name": "Comment le mode de vie affecte-t-il les lymphocytes ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, comme le tabagisme et une mauvaise alimentation, peut affaiblir les lymphocytes." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 02/03/2026

Contenu vérifié selon les dernières recommandations médicales

Sous-catégories

26 au total
└─

Cellules tueuses naturelles

Killer Cells, Natural D007694 - A15.382.490.555.567.537
└─

Sous-populations de lymphocytes

Lymphocyte Subsets D016131 - A15.382.490.555.567.550
└─

Lymphocytes B

B-Lymphocytes D001402 - A15.382.490.555.567.562
└─

Lymphocytes T

T-Lymphocytes D013601 - A15.382.490.555.567.569
└─

Lymphocytes nuls

Lymphocytes, Null D008215 - A15.382.490.555.567.622
└─

Lymphocytes TIL

Lymphocytes, Tumor-Infiltrating D016246 - A15.382.490.555.567.650
└─└─

Cellules LAK

Killer Cells, Lymphokine-Activated D015979 - A15.382.490.555.567.537.500
└─└─

Sous-populations de lymphocytes B

B-Lymphocyte Subsets D016175 - A15.382.490.555.567.562.450
└─└─

Plasmocytes

Plasma Cells D010950 - A15.382.490.555.567.562.725
└─└─

Lymphocytes T CD4+

CD4-Positive T-Lymphocytes D015496 - A15.382.490.555.567.569.200
└─└─

Lymphocytes T CD8+

CD8-Positive T-Lymphocytes D018414 - A15.382.490.555.567.569.220
└─└─

Cellules Jurkat

Jurkat Cells D019169 - A15.382.490.555.567.569.440
└─└─

Cellules T tueuses naturelles

Natural Killer T-Cells D055611 - A15.382.490.555.567.569.470
└─└─

Sous-populations de lymphocytes T

T-Lymphocyte Subsets D016176 - A15.382.490.555.567.569.500
└─└─└─

Lymphocytes B régulateurs

B-Lymphocytes, Regulatory D060151 - A15.382.490.555.567.562.450.300
└─└─└─

Cellules B mémoire

Memory B Cells D000091245 - A15.382.490.555.567.562.450.650
└─└─└─

Lymphocytes intra-épithéliaux

Intraepithelial Lymphocytes D000075942 - A15.382.490.555.567.569.500.050
└─└─└─

Cellules T mémoire

Memory T Cells D000091246 - A15.382.490.555.567.569.500.075
└─└─└─

Cellules T invariantes associées aux muqueuses

Mucosal-Associated Invariant T Cells D000072336 - A15.382.490.555.567.569.500.100
└─└─└─

Lymphocytes T cytotoxiques

T-Lymphocytes, Cytotoxic D013602 - A15.382.490.555.567.569.500.200
└─└─└─

Lymphocytes T auxiliaires

T-Lymphocytes, Helper-Inducer D006377 - A15.382.490.555.567.569.500.400
└─└─└─

Lymphocytes T régulateurs

T-Lymphocytes, Regulatory D050378 - A15.382.490.555.567.569.500.700
└─└─└─└─

Lymphocytes T auxiliaires folliculaires

T Follicular Helper Cells D000084522 - A15.382.490.555.567.569.500.400.450
└─└─└─└─

Lymphocytes auxiliaires Th1

Th1 Cells D018417 - A15.382.490.555.567.569.500.400.900
└─└─└─└─

Lymphocytes auxiliaires Th2

Th2 Cells D018418 - A15.382.490.555.567.569.500.400.905
└─└─└─└─

Cellules Th17

Th17 Cells D058504 - A15.382.490.555.567.569.500.400.915

Auteurs principaux

Joanna Huszno

3 publications dans cette catégorie

Affiliations :
  • I Radiation and Clinic Oncology Department, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland.
  • Genetic Outpatient Clinic, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Gliwice Branch, 44-101 Gliwice, Poland.

Xiaoyu Zhu

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Jia Zhou

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Yu Zhu

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Xiaole Han

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Yunlong Tan

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Ran Li

2 publications dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Zofia Kołosza

2 publications dans cette catégorie

Affiliations :
  • Department of Biostatistics and Bioinformatics, National Research Institute of Oncology, Gliwice, Poland.

Jolanta Mrochem-Kwarciak

2 publications dans cette catégorie

Affiliations :
  • Analytics and Clinical Biochemistry Department, National Research Institute of Oncology, Gliwice, Poland.

Shuo Ma

2 publications dans cette catégorie

Affiliations :
  • 21Robert H. Lurie Comprehensive Cancer Center of Northwestern University.
Publications dans "Lymphocytes" :

Feng Yan

1 publication dans cette catégorie

Affiliations :
  • Peking University HuiLongGuan Clinical Medical School, Beijing HuiLongGuan Hospital, Beijing, P. R. China.
Publications dans "Lymphocytes" :

Donatella Marazziti

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy.
  • Saint Camillus International University of Health and Medical Sciences, Rome, Italy.

Samuele Torrigiani

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy.

Manuel G Carbone

1 publication dans cette catégorie

Affiliations :
  • Department of Medicine and Surgery, Division of Psychiatry, University of Insubria, 21100 Varese, Italy.

Federico Mucci

1 publication dans cette catégorie

Affiliations :
  • Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Italy.

Walter Flamini

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy.

Tea Ivaldi

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy.

Liliana Dell'Osso

1 publication dans cette catégorie

Affiliations :
  • Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Pisa, Italy.

Laura Fusar-Poli

1 publication dans cette catégorie

Affiliations :
  • Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Antimo Natale

1 publication dans cette catégorie

Affiliations :
  • Psychiatry Unit, Department of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.

Sources (3089 au total)

Monocyte-to-lymphocyte, neutrophil-to-lymphocyte and neutrophil-to-monocyte plus lymphocyte ratios in children with active tuberculosis: A multicentre study.

Higher number of monocytes and neutrophils may correlate with active tuberculosis (TB) in children. However, the few paediatric studies available are limited by the small numbers of children with TB d... We calculated the monocyte-to-lymphocyte-ratio (MLR), neutrophil-to-lymphocyte-ratio (NLR) and neutrophil-to-monocyte-plus-lymphocyte-ratio (NMLR) in children with active TB, latent TB infection (LTBI... Overall, 649 children were included (41.8% females, mean age of 5.74 years). MLR, NLR and NMLR values were always significantly higher in patients with TB compared with the other groups (p < 0.001). C... Our study provides further evidence that MLR, NLR and NMLR can serve as first level diagnostics to support the clinical suspicion of TB in children....

Preoperative lymphocyte count, neutrophil to lymphocyte and platelet to lymphocyte ratio predict the recurrence with progression and cancerization in vocal fold lesions-retrospective study.

This study explored the contribution of peripheral blood markers in diagnosis and prognosis estimation of different stages of laryngeal dysplasia and early glottic cancer.... Retrospective analysis of clinical, histopathological and laboratory data of 220 patients including hemoglobin, neutrophil, lymphocyte, monocyte and platelet counts, neutrophil to lymphocyte ratio (NL... The mean hemoglobin level and platelets count showed differences between histopathological stages of lesions (... The levels of blood cells and their ratios seem to be effective in predicting the recurrence of lesion and even more their potential role in indicating malignant progression....

Platelet-to-lymphocyte, neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios are related to cancer-related fatigue and quality of life in patients with cancer: a cross-sectional study.

To explore the association of the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and lymphocyte-to-monocyte ratio (LMR) with cancer-related fatigue (CRF) and quality of life ... A cross-sectional study.... A grade A tertiary hospital in Wuhan, China.... A total of 236 participants were recruited. Participants who were diagnosed with cancer received chemotherapy and/or radiotherapy, and aged ≥18 years were included in this study.... The PLR, NLR and LMR were calculated based on the absolute lymphocyte count, neutrophil count, platelet count and monocyte count. The CRF and QOL of patients after the first chemotherapy/radiotherapy ... The median values (IQR) of PLR, NLR and LMR were 174.51 (126.14-261.02), 2.84 (1.64-5.24) and 2.56 (1.30-3.72), respectively. Univariate analysis indicated that high PLR (≥ 174.51), high NLR (≥ 2.84) ... PLR, NLR and LMR are associated with CRF and QOL in cancer patients. High PLR may predict severe CRF and poor QOL. Further studies are needed to validate these findings based on the expanded sample si...

The Prognosis of Neutrophil-to-Lymphocyte Ratio and Lymphocyte-to-Monocyte Ratio in Elderly with Acute Ischemic Stroke.

Neutrophil-to-lymphocyte ratio (NLR) and Lymphocyte-to-monocyte ratio (LMR) have been reported to be associated with outcomes in acute ischemic stroke. However, research on elderly populations remains... Based on the modified Rankin Score (mRS) on the 90th day after stroke, patients were divided into group and bad prognosis groups. Multivariate logistic regression analysis and receiver operating curve... In total, 824 elderly patients with AIS were enrolled between November 2021 and December 2023. Significant differences emerged in the NLR, LMR, and lymphocyte count between the two groups (P<0.05). Bi... NLR and LMR independently contribute to an unfavorable prognosis in elderly patients with AIS. The area under the ROC curve (AUC) for the combined NLR and LMR was higher than that for NLR and LMR indi...

The association between the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and monocyte-to-lymphocyte ratio and systemic sclerosis and its complications: a systematic review and meta-analysis.

The identification of new, easily measurable biomarkers might assist clinicians in diagnosing and managing systemic sclerosis (SSc). Although the full blood count is routinely assessed in the evaluati... We conducted a systematic review and meta-analysis of studies investigating the NLR, PLR, and MLR, in SSc patients and healthy controls and in SSc patients with and without relevant complications. Pub... In 10 eligible studies, compared to controls, patients with SSc had significantly higher NLR (standard mean difference, SMD=0.68, 95% CI 0.46 to 0.91, p<0.001; I... Pending the results of appropriately designed prospective studies, the results of this systematic review and meta-analysis suggest that blood cell-derived indices of inflammation, particularly the NLR... https://www.crd.york.ac.uk/PROSPERO/, identifier CRD42024520040....